Wecare Probiotics
微康益生菌
Wecare Probiotics (微康益生菌) is a Chinese probiotics company and a Qiming Venture Partners portfolio company, known for its strain R&D and clinically-backed, high-activity probiotic ingredient solutions . Its flagship strain, *Bifidobacterium animalis* subsp. *lactis* BLa80, was approved by China's National Health Commission for inclusion in the official list of strains permitted in infant food — the first mainland-China-developed strain to make that list — and had earlier passed both FDA GRAS self-affirmation and FDA GRAS certification in the US . That's the extent of elsewhere's corpus on the company; deeper details on its founding, scale, or full product line aren't covered here.
AI-generated — may contain errors, please verify.
Coverage
Qiming Venture Partners Weekly | Portfolio Companies Funding and Updates Vol. 29, 2025
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 26, 2025
Join us in spotlighting milestone moments for companies in Qiming Venture Partners' portfolio.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 25, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies

